申请人:Chugai Seiyaku Kabushiki Kaisha
公开号:EP3312172A1
公开(公告)日:2018-04-25
An objective of the present invention is to provide low-molecular-weight compounds that can inhibit Src family kinases. The present invention relates to compounds represented by general formula (I) or pharmacologically acceptable salts thereof. In the formula, Ar1 is optionally substituted C6-10 arylene or 5- to 10-membered heteroarylene, and Ar2 is optionally substituted C6-10 aryl or 5- to 10-membered heteroaryl. R1 and R2 are defined as described in the specification.
本发明的目的是提供可抑制 Src 家族激酶的低分子量化合物。本发明涉及通式(I)所代表的化合物或其药理学上可接受的盐类。式中,Ar1为任选取代的C6-10芳基或5-10元杂芳基,Ar2为任选取代的C6-10芳基或5-10元杂芳基。R1 和 R2 的定义如说明书所述。